Cargando…
Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months
This case-control study estimates the effectiveness of maternal postpartum messenger RNA (mRNA) COVID-19 vaccination against Delta and Omicron SARS-CoV-2 infection and hospitalization in infants younger than 6 months.
Autores principales: | Jorgensen, Sarah C. J., Hernandez, Alejandro, Fell, Deshayne B., Austin, Peter C., D’Souza, Rohan, Guttmann, Astrid, Kwong, Jeffrey C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972229/ https://www.ncbi.nlm.nih.gov/pubmed/36848130 http://dx.doi.org/10.1001/jamapediatrics.2022.6134 |
Ejemplares similares
-
Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study
por: Jorgensen, Sarah C J, et al.
Publicado: (2023) -
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
por: Buchan, Sarah A., et al.
Publicado: (2022) -
Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy
por: Jorgensen, Sarah C. J., et al.
Publicado: (2023) -
Cochlear Implantation after Bacterial Meningitis in Infants Younger Than 9 Months
por: Roukema, B. Y., et al.
Publicado: (2011) -
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
por: Grewal, Ramandip, et al.
Publicado: (2023)